Diabetes and mental ill health comorbidity
Research type
Research Study
Full title
Exploring the Impact of Mental Ill Health on Medication Adherence Behaviour in Patients Diagnosed with Diabetes
IRAS ID
257691
Contact name
Hana Morrissey
Contact email
Sponsor organisation
University of Wolverhampton, Institute of Human Sciences
Clinicaltrials.gov Identifier
n/a, n/a
Duration of Study in the UK
1 years, 6 months, 0 days
Research summary
The prevalence of mental ill health in the general population (1 in every 4 adults) is expected to be the same in special populations such as patients diagnosed with diabetes. Studies shown that long-term conditions are associated with patients experiencing mental ill health problems or disorders and also poor adherence to therapy. This may be caused by the life-long treatment commitment and the loss of motivation and poor self-emotional awareness due to the mental disorders.
In this study we are aiming to screen patients diagnosed with diabetes for anxiety and depression to identify those who have both diabetes and one or both of depression and anxiety. We will, after reviewing their medication, identify the level of their diabetes control and if they have any adherence to therapy issues. We will identify the cause of the non-adherence (intentional or non-intentional) and not only address any identified mental health issues, but also treated or refer for treatment (as applicable) and offer information about their medication and medical conditions to empower them and facilitate self-care. We will then follow the enrolled patients up for 6 months to explore if by improving patients’ mental health, their diabetes control can be improved due to the adherence behaviour change.
This study is designed as a randomised controlled trial to create three groups, A, B and C. The recruitment will be from one site and the activities are undertaken by the independent prescriber who is the enrolled patients' direct primary healthcare provider.
Patients will be provided with written information about the study at the practice reception desk and also a verbal explanation by the researcher if required. Patients who return the participants' signed consent to participate form will be contacted by the researcher to arrange the consultation/s time and date.REC name
East Midlands - Leicester South Research Ethics Committee
REC reference
19/EM/0103
Date of REC Opinion
10 Apr 2019
REC opinion
Unfavourable Opinion